CollPlant Biotechnologies Ltd
Business
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on medical aesthetics and 3D bioprinting of tissues and organs using proprietary plant‑based genetic engineering to produce recombinant human collagen (rhCollagen). It offers rhCollagen‑based bioinks, photocurable and soft tissue dermal fillers, 3D‑bioprinted regenerative breast implants, and collagen‑based wound and tendon matrices, together with manufacturing and supply services. Its business is organized around an rhCollagen production and bioink platform, aesthetic product development, regenerative implants, and orthopedic/wound care offerings. The company sells and licenses products globally through direct sales to partners, distribution agreements in Europe and Asia, and strategic collaborations with large pharma and bioprinter vendors.
Summary from filing dated 2025-03-26
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $2.37M |
| Net income | $-11.49M |
| Total assets | $10.79M |
| Total liabilities | $4.70M |
| Stockholders' equity | $6.08M |
| Operating cash flow | $-9.42M |